These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 31373491)
21. A two-layered machine learning method to identify protein O-GlcNAcylation sites with O-GlcNAc transferase substrate motifs. Kao HJ; Huang CH; Bretaña NA; Lu CT; Huang KY; Weng SL; Lee TY BMC Bioinformatics; 2015; 16 Suppl 18(Suppl 18):S10. PubMed ID: 26680539 [TBL] [Abstract][Full Text] [Related]
22. Generation of an Interactome for the Tetratricopeptide Repeat Domain of O-GlcNAc Transferase Indicates a Role for the Enzyme in Intellectual Disability. Stephen HM; Praissman JL; Wells L J Proteome Res; 2021 Feb; 20(2):1229-1242. PubMed ID: 33356293 [TBL] [Abstract][Full Text] [Related]
23. Substrate and product analogues as human O-GlcNAc transferase inhibitors. Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461 [TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase. Lazarus BD; Roos MD; Hanover JA J Biol Chem; 2005 Oct; 280(42):35537-44. PubMed ID: 16105839 [TBL] [Abstract][Full Text] [Related]
31. Disease related single point mutations alter the global dynamics of a tetratricopeptide (TPR) α-solenoid domain. Llabrés S; Tsenkov MI; MacGowan SA; Barton GJ; Zachariae U J Struct Biol; 2020 Jan; 209(1):107405. PubMed ID: 31628985 [TBL] [Abstract][Full Text] [Related]
32. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741 [TBL] [Abstract][Full Text] [Related]
33. Selvan N; George S; Serajee FJ; Shaw M; Hobson L; Kalscheuer V; Prasad N; Levy SE; Taylor J; Aftimos S; Schwartz CE; Huq AM; Gecz J; Wells L J Biol Chem; 2018 Jul; 293(27):10810-10824. PubMed ID: 29769320 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of a missense mutation in the Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723 [No Abstract] [Full Text] [Related]
35. Mutations in Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052 [No Abstract] [Full Text] [Related]
36. Identification of a Polypeptide Inhibitor of Hammel FA; Payne NC; Marando VM; Mazitschek R; Walker S J Am Chem Soc; 2024 Sep; 146(38):26320-26330. PubMed ID: 39276112 [No Abstract] [Full Text] [Related]
37. A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability. Pravata VM; Gundogdu M; Bartual SG; Ferenbach AT; Stavridis M; Õunap K; Pajusalu S; Žordania R; Wojcik MH; van Aalten DMF FEBS Lett; 2020 Feb; 594(4):717-727. PubMed ID: 31627256 [TBL] [Abstract][Full Text] [Related]
38. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. Lubas WA; Hanover JA J Biol Chem; 2000 Apr; 275(15):10983-8. PubMed ID: 10753899 [TBL] [Abstract][Full Text] [Related]
39. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors. Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374 [TBL] [Abstract][Full Text] [Related]